U.S., Oct. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07208305) titled 'Olanzapine Plus Metoclopramide for the Prevention of Opioid-Induced Nausea and Vomiting' on Sept. 21.
Brief Summary: The goal of this clinical trial is to evaluate the efficacy and safety of olanzapine plus metoclopramide in preventing opioid-induced nausea and vomiting (OINV) in adult patients with advanced cancer who are initiating strong opioid therapy. The main questions it aims to answer are: (1) Does the combination of olanzapine and metoclopramide reduce the incidence of OINV? (2)What adverse events do participants experience when taking the combination of olanzapine and metoclopramide? Researchers will compare the olanzapine-...